Klin Onkol 2025; 38(4): 302-306.
DOI: 10.48095/ccko2025302.
Keywords: retroperitoneal metastasis – lymph node metastasis – leiomyosarcoma – sternum – minimally invasive metastasectomy – adrenalectomy
Authors: Ioannidis Orestis, Kotidis Efstathios, Anestiadou Elissavet, Matzarakis Ioannis, Skliris James Philip, Symeonidis Savvas, Bitsianis Stefanos, Kerasidou Ourania, Kaprianou Magda, Chatzianestiadou Christiana, Salta-Poupnara Eleni, Tserkezidis Freiderikos, Angelopolos Konstantinos, Angelopoulos Stamatios2025-08-15:Laparoscopic resection of retroperitoneal metastasis originating from sternal leiomyosarcoma – a case report
Keywords: retroperitoneal metastasis – lymph node metastasis – leiomyosarcoma – sternum – minimally invasive metastasectomy – adrenalectomy
Authors: Ioannidis Orestis, Kotidis Efstathios, Anestiadou Elissavet, Matzarakis Ioannis, Skliris James Philip, Symeonidis Savvas, Bitsianis Stefanos, Kerasidou Ourania, Kaprianou Magda, Chatzianestiadou Christiana, Salta-Poupnara Eleni, Tserkezidis Freiderikos, Angelopolos Konstantinos, Angelopoulos Stamatios2025-08-15:Laparoscopic resection of retroperitoneal metastasis originating from sternal leiomyosarcoma – a case report
Klin Onkol 2025; 38(4): 307-309.
DOI: 10.48095/ccko2025307.
Authors: Richter Igor, Bartoš Jiří, Dvořák Josef2025-08-15:Commentary on the CheckMate 9ER clinical trial
Authors: Richter Igor, Bartoš Jiří, Dvořák Josef2025-08-15:Commentary on the CheckMate 9ER clinical trial
Klin Onkol 2025; 38(3): 170-176.
DOI: 10.48095/ccko2025170.
Keywords: GIST – imatinib – sunitinib – regorafenib – ripretinib – avapritinib – systemic treatment
Authors: Batko Stanislav2025-06-15:Present management of gastrointestinal stromal tumors
Keywords: GIST – imatinib – sunitinib – regorafenib – ripretinib – avapritinib – systemic treatment
Authors: Batko Stanislav2025-06-15:Present management of gastrointestinal stromal tumors
Klin Onkol 2025; 38(3): 177-184.
DOI: 10.48095/ccko2025177.
Keywords: elderly age – incidence – mortality – cancer
Authors: Ondrušová Martina, Vándor Svidová Soňa, Blažová Adriána, Ondruš Dalibor2025-06-15:Cancer in the elderly in Slovakia
Keywords: elderly age – incidence – mortality – cancer
Authors: Ondrušová Martina, Vándor Svidová Soňa, Blažová Adriána, Ondruš Dalibor2025-06-15:Cancer in the elderly in Slovakia
Klin Onkol 2025; 38(3): 185-191.
DOI: 10.48095/ccko2025185.
Keywords: early cervical cancer – locally advanced cervical cancer – external beam radiotherapy – brachytherapy – pembrolizumab
Authors: Soumarová Renata2025-06-15:Current complex treatment for cervical cancer
Keywords: early cervical cancer – locally advanced cervical cancer – external beam radiotherapy – brachytherapy – pembrolizumab
Authors: Soumarová Renata2025-06-15:Current complex treatment for cervical cancer
Klin Onkol 2025; 38(3): 192-200.
DOI: 10.48095/ccko2025192.
Keywords: carcinoma – non-small-cell lung – Czech Republic – immunotherapy – pembrolizumab monotherapy – programmed death-ligand 1 – real-world data
Authors: Santorelli Melissa L., Chrápavá Marika, Hrabcová Karolína, Bencina Goran, Blažek Jiří , Bratová Monika , Fibigr Ondřej, Fischer Ondřej, Koubková Leona, Krejčí Jana, Ryška Aleš, Zemanová Petra, Burke Thomas2025-06-15:Real-world PD-L1 testing, first-line therapy for advanced NSCLC, and first-line pembrolizumab monotherapy utilization and outcomes for metastatic NSCLC in the Czech Republic
Keywords: carcinoma – non-small-cell lung – Czech Republic – immunotherapy – pembrolizumab monotherapy – programmed death-ligand 1 – real-world data
Authors: Santorelli Melissa L., Chrápavá Marika, Hrabcová Karolína, Bencina Goran, Blažek Jiří , Bratová Monika , Fibigr Ondřej, Fischer Ondřej, Koubková Leona, Krejčí Jana, Ryška Aleš, Zemanová Petra, Burke Thomas2025-06-15:Real-world PD-L1 testing, first-line therapy for advanced NSCLC, and first-line pembrolizumab monotherapy utilization and outcomes for metastatic NSCLC in the Czech Republic
Klin Onkol 2025; 38(3): 201-208.
DOI: 10.48095/ccko2025201.
Keywords: cancer of the uterine cervix – operative surgical procedure – intermediate-risk factors – adjuvant radiotherapy
Authors: Sorokin Pavel, Kulikova Svetlana, Stepanyan Artem, Davtyan Hasmik, Kuryllo Marek, Oliveira Rivadavio, Rezende Bruno2025-06-15:Total mesometrial resection for the treatment of cervical cancer – an exploratory study of feasibility, safety and oncological outcomes in developing countries
Keywords: cancer of the uterine cervix – operative surgical procedure – intermediate-risk factors – adjuvant radiotherapy
Authors: Sorokin Pavel, Kulikova Svetlana, Stepanyan Artem, Davtyan Hasmik, Kuryllo Marek, Oliveira Rivadavio, Rezende Bruno2025-06-15:Total mesometrial resection for the treatment of cervical cancer – an exploratory study of feasibility, safety and oncological outcomes in developing countries
Klin Onkol 2025; 38(3): 209-212.
DOI: 10.48095/ccko2025209.
Keywords: cefiderocol – Pseudomonas aeruginosa – sepsis
Authors: Navrátil Milan2025-06-15:Successful treatment of sepsis caused by multidrug-resistant Pseudomonas aeruginosa using cefiderocol in an immunocompromised hematological cancer patient following allogeneic hematopoietic stem cell transplantation
Keywords: cefiderocol – Pseudomonas aeruginosa – sepsis
Authors: Navrátil Milan2025-06-15:Successful treatment of sepsis caused by multidrug-resistant Pseudomonas aeruginosa using cefiderocol in an immunocompromised hematological cancer patient following allogeneic hematopoietic stem cell transplantation
Klin Onkol 2025; 38(3): 213-217.
DOI: 10.48095/ccko2025213.
Keywords: malignant – undifferentiated tumor – lung – rapid growth – immune checkpoint inhibitor – long-term efficacy
Authors: Maezawa Yosuke, Sasatani Yuika, Ohara Gen, Okauchi Shinichiro, Kawai Hitomi, Satoh Hiroaki2025-06-15:Long-term treatment efficacy in a rapid growth malignant undifferentiated lung tumor
Keywords: malignant – undifferentiated tumor – lung – rapid growth – immune checkpoint inhibitor – long-term efficacy
Authors: Maezawa Yosuke, Sasatani Yuika, Ohara Gen, Okauchi Shinichiro, Kawai Hitomi, Satoh Hiroaki2025-06-15:Long-term treatment efficacy in a rapid growth malignant undifferentiated lung tumor
Klin Onkol 2025; 38(3): 218-223.
DOI: 10.48095/ccko2025218.
Keywords: ovarian cancer – PARP inhibitors – indication criteria – PARPi
Authors: Cibula David, Kocián Roman2025-06-15:Praktická doporučení pro indikace inhibitorů PARP v léčbě ovariálního karcinomu Practical recommendations for the use of PARP inhibitors in the treatment of ovarian cancer
Keywords: ovarian cancer – PARP inhibitors – indication criteria – PARPi
Authors: Cibula David, Kocián Roman2025-06-15:Praktická doporučení pro indikace inhibitorů PARP v léčbě ovariálního karcinomu Practical recommendations for the use of PARP inhibitors in the treatment of ovarian cancer
Klin Onkol 2025; 38(3): 224-232.
DOI: 10.48095/ccko2025224.
Keywords: chemotherapy – anticancer treatment – nursing – extravasation – venous access devices – antidotes
Authors: Vokurka Samuel, Maňásek Viktor, Navrátilová Hrabánková Darja, Rozsívalová Petra, Kletečka Jakub, Šípová Simona , Pavlicová Vladislava, Žák Pavel, Kozáková Šárka, Vlasáková Adéla, Brojáčová Danka, Turková Lenka, Víšek Benjamin2025-06-15:Extravasation (paravasation) of anticancer drugs – updated recommendations (2025) for standard care in the Czech Republic based on multidisciplinary cooperation
Keywords: chemotherapy – anticancer treatment – nursing – extravasation – venous access devices – antidotes
Authors: Vokurka Samuel, Maňásek Viktor, Navrátilová Hrabánková Darja, Rozsívalová Petra, Kletečka Jakub, Šípová Simona , Pavlicová Vladislava, Žák Pavel, Kozáková Šárka, Vlasáková Adéla, Brojáčová Danka, Turková Lenka, Víšek Benjamin2025-06-15:Extravasation (paravasation) of anticancer drugs – updated recommendations (2025) for standard care in the Czech Republic based on multidisciplinary cooperation
Klin Onkol 2025; 38(2): 90-96.
DOI: 10.48095/ccko202590.
Keywords: cemiplimab – advanced non-small cell lung cancer – immunotherapy – PD-1 – PD-L1
Authors: Koubková Leona2025-04-15:Cemiplimab in the treatment of non-small cell lung cancer
Keywords: cemiplimab – advanced non-small cell lung cancer – immunotherapy – PD-1 – PD-L1
Authors: Koubková Leona2025-04-15:Cemiplimab in the treatment of non-small cell lung cancer
Klin Onkol 2025; 38(2): 97-103.
DOI: 10.48095/ccko202597.
Keywords: lung cancer – quality of life – oncological treatment
Authors: Bratová Monika , Jakubíková Lenka, Kultan Juraj, Svatoň Martin, Svoboda Michal, Brat Kristián2025-04-15:The lung cancer patient quality of life during the first line of treatment – multicenter prospective data
Keywords: lung cancer – quality of life – oncological treatment
Authors: Bratová Monika , Jakubíková Lenka, Kultan Juraj, Svatoň Martin, Svoboda Michal, Brat Kristián2025-04-15:The lung cancer patient quality of life during the first line of treatment – multicenter prospective data
Klin Onkol 2025; 38(2): 104-109.
DOI: 10.48095/ccko2025104.
Keywords: leukemia – children –anxiety – fatigue – rhythmic movements
Authors: Kahkhaei Fateme Rezaei , Ghotb Abadi Azam Amandadi, Ghaljaei Fereshteh2025-04-15:The effect of rhythmic movements on anxiety and fatigue of children with leukemia – a quasi-experimental study
Keywords: leukemia – children –anxiety – fatigue – rhythmic movements
Authors: Kahkhaei Fateme Rezaei , Ghotb Abadi Azam Amandadi, Ghaljaei Fereshteh2025-04-15:The effect of rhythmic movements on anxiety and fatigue of children with leukemia – a quasi-experimental study
Klin Onkol 2025; 38(2): 110-118.
DOI: 10.48095/ccko2025110.
Keywords: non-randomized controlled trial – breast cancer survivors – cardiorespiratory fitness – bone quality – well-being – adherence
Authors: Šimonová Marie2025-04-15:Adherence to an exercise program and its impact on physical fitness, bone density and quality of life in women after breast cancer treatment
Keywords: non-randomized controlled trial – breast cancer survivors – cardiorespiratory fitness – bone quality – well-being – adherence
Authors: Šimonová Marie2025-04-15:Adherence to an exercise program and its impact on physical fitness, bone density and quality of life in women after breast cancer treatment